Eiken Chemical Co., Ltd. (TYO:4549)
Japan · Delayed Price · Currency is JPY 2,560.00
-8.00 (-0.31%)
Feb 13, 2026, 3:30 PM JST
Eiken Chemical Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 41,276 | 40,539 | 40,052 | 43,271 | 42,996 | 38,667 | |
Revenue Growth (YoY) | 2.68% | 1.22% | -7.44% | 0.64% | 11.20% | 5.69% |
Cost of Revenue | 24,917 | 24,027 | 23,328 | 22,765 | 22,423 | 20,140 |
Gross Profit | 16,359 | 16,512 | 16,724 | 20,506 | 20,573 | 18,527 |
Selling, General & Admin | 13,215 | 13,512 | 13,345 | 8,963 | 8,776 | 8,829 |
Research & Development | - | - | - | 4,065 | 3,408 | 3,086 |
Operating Expenses | 13,215 | 13,512 | 13,345 | 13,049 | 12,184 | 11,914 |
Operating Income | 3,144 | 3,000 | 3,379 | 7,457 | 8,389 | 6,613 |
Interest Expense | -19 | -17 | -17 | -16 | -29 | -2 |
Interest & Investment Income | 20 | 17 | 12 | 18 | 20 | 19 |
Currency Exchange Gain (Loss) | -28 | 1 | 50 | 14 | 32 | - |
Other Non Operating Income (Expenses) | 38 | 133 | 143 | 108 | 95 | 178 |
EBT Excluding Unusual Items | 5,093 | 3,134 | 3,567 | 7,581 | 8,507 | 6,808 |
Merger & Restructuring Charges | -250 | -250 | - | - | - | - |
Gain (Loss) on Sale of Investments | - | 49 | - | 43 | - | -1 |
Gain (Loss) on Sale of Assets | -13 | -6 | -65 | -33 | -26 | -48 |
Other Unusual Items | 15 | 64 | - | 1 | - | 110 |
Pretax Income | 4,845 | 2,991 | 3,502 | 7,592 | 8,481 | 6,869 |
Income Tax Expense | 1,011 | 763 | 868 | 1,856 | 2,263 | 1,825 |
Net Income | 3,834 | 2,228 | 2,634 | 5,736 | 6,218 | 5,044 |
Net Income to Common | 3,834 | 2,228 | 2,634 | 5,736 | 6,218 | 5,044 |
Net Income Growth | 75.95% | -15.41% | -54.08% | -7.75% | 23.28% | 42.57% |
Shares Outstanding (Basic) | 33 | 34 | 37 | 37 | 37 | 37 |
Shares Outstanding (Diluted) | 33 | 35 | 37 | 37 | 37 | 37 |
Shares Change (YoY) | -5.29% | -6.43% | -0.62% | 0.12% | 0.10% | 0.09% |
EPS (Basic) | 115.61 | 64.82 | 71.69 | 155.17 | 168.26 | 136.63 |
EPS (Diluted) | 115.14 | 64.27 | 71.10 | 153.86 | 167.01 | 135.60 |
EPS Growth | 85.76% | -9.61% | -53.79% | -7.87% | 23.16% | 42.42% |
Free Cash Flow | - | 819 | 1,830 | 4,369 | 3,341 | 3,897 |
Free Cash Flow Per Share | - | 23.63 | 49.39 | 117.19 | 89.72 | 104.75 |
Dividend Per Share | 56.000 | 53.000 | 51.000 | 51.000 | 51.000 | 41.000 |
Dividend Growth | 7.69% | 3.92% | - | - | 24.39% | 36.67% |
Gross Margin | 39.63% | 40.73% | 41.76% | 47.39% | 47.85% | 47.91% |
Operating Margin | 7.62% | 7.40% | 8.44% | 17.23% | 19.51% | 17.10% |
Profit Margin | 9.29% | 5.50% | 6.58% | 13.26% | 14.46% | 13.05% |
Free Cash Flow Margin | - | 2.02% | 4.57% | 10.10% | 7.77% | 10.08% |
EBITDA | 5,400 | 5,286 | 5,705 | 9,582 | 10,447 | 8,324 |
EBITDA Margin | 13.08% | 13.04% | 14.24% | 22.14% | 24.30% | 21.53% |
D&A For EBITDA | 2,256 | 2,286 | 2,326 | 2,125 | 2,058 | 1,711 |
EBIT | 3,144 | 3,000 | 3,379 | 7,457 | 8,389 | 6,613 |
EBIT Margin | 7.62% | 7.40% | 8.44% | 17.23% | 19.51% | 17.10% |
Effective Tax Rate | 20.87% | 25.51% | 24.79% | 24.45% | 26.68% | 26.57% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.